Mirghasemi Seyed Alireza, Trepman Elly, Sadeghi Mohammad Saleh, Rahimi Narges, Rashidinia Shervin
Orthopedic Surgery, Qom University of Medical Sciences, Qom, Iran
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Foot Ankle Int. 2016 Dec;37(12):1364-1373. doi: 10.1177/1071100716664783. Epub 2016 Sep 1.
Bone marrow edema syndrome (BMES) is an uncommon and self-limited syndrome characterized by extremity pain of unknown etiology. Symptoms may include sudden or gradual onset of swelling and pain at rest or during activity, usually at night. This syndrome mostly affects middle-aged men and younger women who have pain in the lower extremities. The most common sites involved with BMES, in decreasing order of frequency, are the bones about the hip, knee, ankle, and foot. The diagnosis of BMES is confirmed with magnetic resonance imaging to exclude other causes of bone marrow edema. The correct diagnosis in the foot and ankle often is delayed because of the low prevalence and nonspecific signs. This delay may intensify bone pain and impair patient function and quality of life. The goal of BMES treatment is to relieve pain and shorten disease duration. Treatment options are limited and may include symptomatic treatment, pharmacologic treatment, and surgery.
Level V, expert opinion.
骨髓水肿综合征(BMES)是一种罕见的自限性综合征,其特征为病因不明的肢体疼痛。症状可能包括休息或活动时(通常在夜间)突然或逐渐出现的肿胀和疼痛。该综合征主要影响下肢疼痛的中年男性和年轻女性。BMES最常累及的部位,按频率递减顺序依次为髋部、膝部、踝部和足部周围的骨骼。BMES的诊断通过磁共振成像得以证实,以排除骨髓水肿的其他病因。由于发病率低且体征不具特异性,足踝部的正确诊断往往延迟。这种延迟可能会加剧骨痛,并损害患者的功能和生活质量。BMES治疗的目标是缓解疼痛并缩短病程。治疗选择有限,可能包括对症治疗、药物治疗和手术。
V级,专家意见。